CHUGAI PHARMACEUTICAL CO., LTD. Logo

CHUGAI PHARMACEUTICAL CO., LTD.

An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.

4519 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
北区浮間五丁目5番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Chugai Pharmaceutical Co., Ltd. is a research and development-oriented pharmaceutical company and a member of the Roche Group. The company specializes in creating innovative prescription drugs to address unmet medical needs, leveraging its unique science and proprietary antibody engineering technologies. Chugai's growth strategy is driven by a shift towards discovery research and early clinical development, the application of digital technology (DX) across its value chain, and open innovation through external partnerships. It is a leading presence in the Japanese therapeutic antibody market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-25 08:42
Interim Report
確認書
Japanese 9.6 KB
2025-07-25 08:40
Interim Report
半期報告書-第115期(2025/01/01-2025/12/31)
Japanese 298.8 KB
2025-04-22 09:07
Regulatory News Service
訂正臨時報告書
Japanese 39.1 KB
2025-03-28 06:43
Post-Annual General Meeting Information
臨時報告書
Japanese 27.8 KB
2025-03-27 08:12
Regulatory News Service
臨時報告書
Japanese 39.7 KB
2025-03-27 07:57
Governance Information
内部統制報告書-第114期(2024/01/01-2024/12/31)
Japanese 24.8 KB
2025-03-27 07:50
Registration Form
確認書
Japanese 9.6 KB
2025-03-27 07:48
Annual Report
有価証券報告書-第114期(2024/01/01-2024/12/31)
Japanese 3.3 MB
2024-07-26 08:02
Regulatory News Service
確認書
Japanese 9.6 KB
2024-07-26 08:01
Interim Report
半期報告書-第114期(2024/01/01-2024/12/31)
Japanese 330.6 KB
2024-07-26 07:35
Regulatory News Service
確認書
Japanese 9.6 KB
2024-07-26 07:30
Regulatory News Service
訂正有価証券報告書-第113期(2023/01/01-2023/12/31)
Japanese 1.8 MB
2024-04-25 08:09
Regulatory News Service
確認書
Japanese 9.6 KB
2024-04-25 08:07
Quarterly Report
四半期報告書-第114期第1四半期(2024/01/01-2024/03/31)
Japanese 272.0 KB
2024-04-24 08:21
Registration Form
確認書
Japanese 9.6 KB

Automate Your Workflow. Get a real-time feed of all CHUGAI PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CHUGAI PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
A biotech firm in biopharma, diagnostics, digital health, and consumer wellness products.
South Korea 005250
GREEN CROSS WellBeing Corporation Logo
Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.
South Korea 234690
Grifols S.A. Logo
Leading producer of plasma-derived medicines for patients with rare and chronic diseases.
Spain GRF
Grindeks Logo
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
Latvia GRD1R
Guard Therapeutics International AB Logo
Clinical-stage biotech developing drugs to prevent acute kidney injury during open-heart surgery.
Sweden GUARD
Develops research antibodies and distributes scientific instruments for life science researchers.
South Korea 036180
Haleon PLC Logo
A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.
United Kingdom HLN
Halychpharm Logo
A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.
Ukraine GFARM
HANALL BIOPHARMA CO.,LTD Logo
Develops innovative medicines for chronic diseases through antibody and small molecule research.
South Korea 009420
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480

Talk to a Data Expert

Have a question? We'll get back to you promptly.